(BCCMS) UBS (Irl) Fund Solutions - Ratings and Ratios
Energy, Metals, Agricultural Products
Description: BCCMS UBS (Irl) Fund Solutions
The UBS (Irl) Fund Solutions plc - Bloomberg Commodity CMCI SF UCITS ETF (hedged to CHF) A-acc is designed to mirror the performance of the UBS Bloomberg BCOM Constant Maturity Commodity Index Total Return. This means its primary goal is to provide investors with exposure to a broad range of commodities, allowing them to capitalize on trends and fluctuations in the commodity markets.
As a commodities-focused ETF, it offers a diversified investment portfolio that includes various commodity sectors, potentially reducing risk through broad exposure. The funds hedging to CHF mitigates currency risk for investors holding Swiss Francs, making it an attractive option for those seeking commodity exposure without the additional volatility associated with currency fluctuations.
Analyzing the provided technical data, the ETF is currently priced at 13.28, slightly above its 20-day Simple Moving Average (SMA) of 13.17, indicating a short-term bullish trend. The 50-day SMA is at 13.29, very close to the current price, suggesting a stable medium-term outlook. The 200-day SMA at 12.91 is significantly lower, indicating a longer-term uptrend. The Average True Range (ATR) is 0.18, or 1.37% of the current price, suggesting moderate volatility.
Using the technical and fundamental data, a forecast can be constructed. Given the current price is above both the 20-day and 200-day SMAs, and considering the AUM of 250.47M CHF indicates a decent level of investor interest and liquidity, a cautiously optimistic outlook can be maintained. The proximity of the current price to its 52-week high of 13.80 suggests potential for further growth, albeit with the risk of retreating to the mean if the commodity markets experience a downturn. The ATR indicates that while there is some volatility, it is not extreme, suggesting that the ETF could be a relatively stable way to gain commodity exposure.
Forecasting, if the commodity markets continue to trend positively, and given the ETFs diversified exposure, its plausible that the ETF could reach or slightly exceed its 52-week high in the near term. However, investors should be cautious of market downturns and adjust their strategies accordingly. A prudent approach would be to monitor the ETFs price action relative to its SMAs and adjust expectations based on changes in commodity market trends and overall economic conditions.
Additional Sources for BCCMS ETF
BCCMS ETF Overview
Market Cap in USD | 317m |
Category | Commodities - Broad Basket |
TER | 0.30% |
IPO / Inception | 2017-05-25 |
BCCMS ETF Ratings
Growth Rating | 47.4 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 3.1 |
Analysts | - |
Fair Price Momentum | 12.59 CHF |
Fair Price DCF | - |
BCCMS Dividends
Currently no dividends paidBCCMS Growth Ratios
Growth Correlation 3m | 58.3% |
Growth Correlation 12m | 74.5% |
Growth Correlation 5y | 39.8% |
CAGR 5y | 11.34% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | -0.32 |
Alpha | -4.90 |
Beta | 0.191 |
Volatility | 16.51% |
Current Volume | 37.4k |
Average Volume 20d | 18.3k |
As of July 06, 2025, the stock is trading at CHF 13.24 with a total of 37,351 shares traded.
Over the past week, the price has changed by +1.78%, over one month by +1.40%, over three months by +3.75% and over the past year by +2.87%.
Partly, yes. Based on ValueRay´s Analyses, UBS (Irl) Fund Solutions (SW:BCCMS) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.40 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCCMS is around 12.59 CHF . This means that BCCMS is currently overvalued and has a potential downside of -4.91%.
UBS (Irl) Fund Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, BCCMS UBS (Irl) Fund Solutions will be worth about 13.7 in July 2026. The stock is currently trading at 13.24. This means that the stock has a potential upside of +3.63%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 13.7 | 3.6% |